FRAZIER MANAGEMENT LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 137 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
FRAZIER MANAGEMENT LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$54,984,000
+81.6%
3,123,1070.0%4.40%
+57.6%
Q2 2021$30,275,000
-9.4%
3,123,1070.0%2.79%
+4.2%
Q1 2021$33,419,000
-25.5%
3,123,107
+2.3%
2.68%
-22.5%
Q4 2020$44,879,000
+13.5%
3,053,107
+9.5%
3.46%
-2.7%
Q3 2020$39,555,000
+77.5%
2,788,443
+1.2%
3.55%
+81.5%
Q2 2020$22,288,000
+133.3%
2,755,000
+12.7%
1.96%
+80.7%
Q1 2020$9,552,0002,443,8091.08%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders